Form 8-K - Current report:
SEC Accession No. 0001193125-24-135721
Filing Date
2024-05-10
Accepted
2024-05-10 07:01:05
Documents
55
Period of Report
2024-05-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d820291d8k.htm   iXBRL 8-K 25774
2 EX-99.1 d820291dex991.htm EX-99.1 49893
6 GRAPHIC g820291ex99_1s10g1.jpg GRAPHIC 116322
7 GRAPHIC g820291ex99_1s11g1.jpg GRAPHIC 97901
8 GRAPHIC g820291ex99_1s12g1.jpg GRAPHIC 95232
9 GRAPHIC g820291ex99_1s13g1.jpg GRAPHIC 95905
10 GRAPHIC g820291ex99_1s14g1.jpg GRAPHIC 138033
11 GRAPHIC g820291ex99_1s15g1.jpg GRAPHIC 133950
12 GRAPHIC g820291ex99_1s16g1.jpg GRAPHIC 97652
13 GRAPHIC g820291ex99_1s17g1.jpg GRAPHIC 114212
14 GRAPHIC g820291ex99_1s18g1.jpg GRAPHIC 49235
15 GRAPHIC g820291ex99_1s19g1.jpg GRAPHIC 108913
16 GRAPHIC g820291ex99_1s1g1.jpg GRAPHIC 70797
17 GRAPHIC g820291ex99_1s20g1.jpg GRAPHIC 105328
18 GRAPHIC g820291ex99_1s21g1.jpg GRAPHIC 87184
19 GRAPHIC g820291ex99_1s22g1.jpg GRAPHIC 73963
20 GRAPHIC g820291ex99_1s23g1.jpg GRAPHIC 88339
21 GRAPHIC g820291ex99_1s24g1.jpg GRAPHIC 73084
22 GRAPHIC g820291ex99_1s25g1.jpg GRAPHIC 61046
23 GRAPHIC g820291ex99_1s26g1.jpg GRAPHIC 88901
24 GRAPHIC g820291ex99_1s27g1.jpg GRAPHIC 132609
25 GRAPHIC g820291ex99_1s28g1.jpg GRAPHIC 122588
26 GRAPHIC g820291ex99_1s29g1.jpg GRAPHIC 86154
27 GRAPHIC g820291ex99_1s2g1.jpg GRAPHIC 225950
28 GRAPHIC g820291ex99_1s30g1.jpg GRAPHIC 88324
29 GRAPHIC g820291ex99_1s31g1.jpg GRAPHIC 111744
30 GRAPHIC g820291ex99_1s32g1.jpg GRAPHIC 123215
31 GRAPHIC g820291ex99_1s33g1.jpg GRAPHIC 60710
32 GRAPHIC g820291ex99_1s34g1.jpg GRAPHIC 145430
33 GRAPHIC g820291ex99_1s35g1.jpg GRAPHIC 64461
34 GRAPHIC g820291ex99_1s36g1.jpg GRAPHIC 32015
35 GRAPHIC g820291ex99_1s37g1.jpg GRAPHIC 130829
36 GRAPHIC g820291ex99_1s38g1.jpg GRAPHIC 89623
37 GRAPHIC g820291ex99_1s39g1.jpg GRAPHIC 89262
38 GRAPHIC g820291ex99_1s3g1.jpg GRAPHIC 119585
39 GRAPHIC g820291ex99_1s40g1.jpg GRAPHIC 90561
40 GRAPHIC g820291ex99_1s41g1.jpg GRAPHIC 88065
41 GRAPHIC g820291ex99_1s4g1.jpg GRAPHIC 119016
42 GRAPHIC g820291ex99_1s5g1.jpg GRAPHIC 108567
43 GRAPHIC g820291ex99_1s6g1.jpg GRAPHIC 132300
44 GRAPHIC g820291ex99_1s7g1.jpg GRAPHIC 121095
45 GRAPHIC g820291ex99_1s8g1.jpg GRAPHIC 125587
46 GRAPHIC g820291ex99_1s9g1.jpg GRAPHIC 127782
  Complete submission text file 0001193125-24-135721.txt   6053400

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA spry-20240510.xsd EX-101.SCH 2847
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE spry-20240510_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spry-20240510_pre.xml EX-101.PRE 11705
58 EXTRACTED XBRL INSTANCE DOCUMENT d820291d8k_htm.xml XML 3773
Mailing Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL, SUITE 120 SAN DIEGO CA 92130 858-771-9307
ARS Pharmaceuticals, Inc. (Filer) CIK: 0001671858 (see all company filings)

EIN.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 24932835
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)